share_log

AbbVie Names Robert A. Michael CEO; Richard A. Gonzalez To Become Executive Chairman

Benzinga ·  Jul 1 20:11
  • As Previously Announced, Richard A. Gonzalez Retires as Chief Executive Officer to Become Executive Chairman
  • Robert A. Michael Joins AbbVie Board of Directors

NORTH CHICAGO, Ill., July 1, 2024 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced that Robert A. Michael has assumed the role of chief executive officer (CEO) and has joined AbbVie's Board of Directors, effective today. As previously announced, Mr. Michael succeeds Richard A. Gonzalez, who has served as CEO since the company's inception in 2013. Mr. Gonzalez has become executive chairman of the board of directors.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment